Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
125I-MAB 425 for High Grade Gliomas
NCT00589706Phase 2Completed
- Sponsor
- Drexel University
- Start
- Jan 1985
- Primary completion
- Dec 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of Iodine-125-labeled monoclonal antibody 425 in high-grade glioma (HGG), sponsored by Drexel University. Started Jan 1985; status: completed.
02
Drugs
Iodine-125-labeled monoclonal antibody 425
03
Conditions
high-grade glioma (HGG)
Beyond the preview
Go deeper on NCT00589706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00589706.